You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 21, 2024

Litigation Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Details for Alvotech USA Inc. v. Abbvie Inc (E.D. Va. 2021)

Date Filed Document No. Description Snippet Link To Document
2021-05-11 1 THE PATENTS-IN-SUIT U.S. Patent No. 8,420,081 78.…78. U.S. Patent No. 8,420,081 (“the ’081 patent”), titled “Antibody Formulations and Methods of Making…the way for market entry of AVT02: U.S. Patent Nos. 8,420,081; 9,085,619; 8,926,975; and 8,961,973. …Declaratory Judgment of Non-infringement of U.S. Patent No. 8,420,081) 82. Plaintiffs re-allege the…Declaratory Judgment of Invalidity of U.S. Patent No. 8,420,081) 87. Plaintiffs re-allege External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.